IRINA LAZAROVICH: Open Payments
NPI 1710043229 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 13 payments from 9 companies in 2025. Trend: 2023 $911 · 2024 $1,234 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| Medtronic, Inc. | 1 | $39 |
| Novo Nordisk Inc | 1 | $28 |
| ABBVIE INC. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| CeQur Corporation | 1 | $19 |
| Ardelyx, Inc. | 1 | $15 |
Products named: JARDIANCE, LEQVIO, MINIMED 780G, Wegovy, LINZESS, RECORLEV, OTEZLA, CeQur Simplicity.
Industry payments across NY — which companies pay providers there.
